Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer

International Journal of Cancer

Volumn 144, Issue 8, 2019, Pages 2020-2032

  Yang, Ying Gui ^a   Koh, Young Wha ^b   Sari, Ita Novita ^a   Jun, Nayoung ^a   Lee, Sanghyun ^a   Phi, Lan Thi Hanh ^a   Kim, Kwang Seock ^a   Wijaya, Yoseph Toni ^a   Lee, Sang Hun ^a   Baek, Moo Jun ^a   Jeong, Dongjun ^a   Kwon, Hyog Young ^a  

^a Soonchunhyang University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

adenocarcinoma; CSC; EGFR; EMT; IFITM1; NSCLC; SOX2

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; EGFR PROTEIN, HUMAN; LEU-13 ANTIGEN; SMALL INTERFERING RNA; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DISEASE MARKER; EGFR SOX2 SIGNALING; EPITHELIAL MESENCHYMAL TRANSITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MTT ASSAY; NON SMALL CELL LUNG CANCER; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; ADULT; AGED; ANIMAL; DISEASE EXACERBATION; DRUG SCREENING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG; LUNG ADENOCARCINOMA; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NONOBESE DIABETIC MOUSE; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TUMOR CELL LINE; VERY ELDERLY;

ADENOCARCINOMA OF LUNG; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, DIFFERENTIATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DISEASE PROGRESSION; ERBB RECEPTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE, INBRED NOD; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85058105718     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.31926     Document Type: Article

References (60)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86
2. Jemal A, Center MM, Ward E, et al. Cancer occurrence. Methods Mol Biol 2009;471:3–29
3. Swiderska M, Choromanska B, Dabrowska E, et al. The diagnostics of colorectal cancer. Contemp Oncol (Pozn) 2014;18:1–6
4. Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 2013;19:1438–49
5. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871–90
6. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265–73
7. Alamgeer M, Peacock CD, Matsui W, et al. Cancer stem cells in lung cancer: evidence and controversies. Respirology 2013;18:757–64
8. Houthuijzen JM, Daenen LG, Roodhart JM, et al. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer 2012;106:1901–6
9. Leprieur EG, Tolani B, Li H, et al. Membrane-bound full-length sonic hedgehog identifies cancer stem cells in human non-small cell lung cancer. Oncotarget 2017;8:103744–57
10. Gong L, Song J, Lin X, et al. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/beta-catenin signalling in NSCLC. J Pathol 2016;240:184–96
11. Abhold EL, Kiang A, Rahimy E, et al. EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS One 2012;7:e32459
12. Rybak AP, Tang D. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cell Signal 2013;25:2734–42
13. Maruyama IN. Mechanisms of activation of receptor tyrosine kinases: monomers or dimers. Cell 2014;3:304–30
14. Prasad SB, Yadav SS, Das M, et al. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Cell Oncol 2015;38:215–25
15. Sweeny L, Dean NR, Magnuson JS, et al. EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck 2012;34:681–6
16. Paugh BS, Zhu X, Qu C, et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 2013;73:6219–29
17. Li T, Kung HJ, Mack PC, et al. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol 2013;31:1039–49
18. Deng Y, Kurland BF, Wang J, et al. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Am J Clin Oncol 2009;32:245–52
19. Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 2007;43:193–8
20. Peled N, Yoshida K, Wynes MW, et al. Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer. Ther Adv Med Oncology 2009;1:137–44
21. Scagliotti GV, Selvaggi G, Novello S, et al. The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res 2004;10:4227s–32s
22. Takahashi S, Doss C, Levy S, et al. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 1990;145:2207–13
23. Bradbury LE, Kansas GS, Levy S, et al. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 1992;149:2841–50
24. Lewin AR, Reid LE, McMahon M, et al. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 1991;199:417–23
25. Sato S, Miller AS, Howard MC, et al. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol 1997;159:3278–87
26. Chattopadhyay I, Phukan R, Singh A, et al. Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering. Oncol Rep 2009;21:1135–46
27. Hatano H, Kudo Y, Ogawa I, et al. IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 2008;14:6097–105
28. Sari IN, Yang YG, Phi LT, et al. Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer. Oncotarget 2016;7:86039–50
29. Leung EL, Fiscus RR, Tung JW, et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 2010;5:e14062
30. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243–60
31. Gyorffy B, Dietel M, Fekete T, et al. A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma. Int J Gynecol Cancer 2008;18:1215–33
32. Seyfried NT, Huysentruyt LC, Atwood JA 3rd, et al. Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett 2008;263:243–52
33. Bailey CC, Zhong G, Huang IC, et al. IFITM-family proteins: the Cell's first line of antiviral defense. Annu Rev Virol 2014;1:261–83
34. Yu F, Ng SS, Chow BK, et al. Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells. J Neurooncol 2011;103:187–95
35. Yu F, Xie D, Ng SS, et al. IFITM1 promotes the metastasis of human colorectal cancer via CAV-1. Cancer Lett 2015;368:135–43
36. Senetta R, Miracco C, Lanzafame S, et al. Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes. Neuro Oncol 2011;13:176–83
37. Jankovic J, Tatic S, Bozic V, et al. Inverse expression of caveolin-1 and EGFR in thyroid cancer patients. Hum Pathol 2017;61:164–72
38. Cui Y, Zhu T, Song X, et al. Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation. Biochem Biophys Res Commun 2018;495:733–9
39. Lu Z, Ghosh S, Wang Z, et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003;4:499–515
40. Shafarenko M, Liebermann DA, Hoffman B. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation. Blood 2005;106:871–8
41. Kwan KY, Shen J, Corey DP. C-MYC transcriptionally amplifies SOX2 target genes to regulate self-renewal in multipotent otic progenitor cells. Stem Cell Rep 2015;4:47–60
42. Park SB, Seo KW, So AY, et al. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ 2012;19:534–45
43. Boone DN, Qi Y, Li Z, et al. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci U S A 2011;108:632–7
44. Liu D, Li WM, Mo XM, et al. Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cell. Sichuan Da Xue Xue Bao Yi Xue Ban 2008;39:827–31
45. Chan KM, Wu TH, Cheng CH, et al. Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol 2014;12:155
46. Okudela K, Woo T, Mitsui H, et al. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and beta-catenin, in primary lung adenocarcinoma--their prognostic significance. Pathol Int 2012;62:792–801
47. Andreu P, Colnot S, Godard C, et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 2006;66:1949–55
48. Kim JY, Kim WJ, Kim H, et al. The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis. Immune Netw 2009;9:90–7
49. Kim JY, Kim H, Suk K, et al. Activation of CD147 with cyclophilin a induces the expression of IFITM1 through ERK and PI3K in THP-1 cells. Mediators Inflamm 2010;2010:821940–9
50. Gaedcke J, Grade M, Jung K, et al. Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer 2010;49:1024–34
51. de la Rocha AM, Sampron N, Alonso MM, et al. Role of SOX family of transcription factors in central nervous system tumors. Am J Cancer Res 2014;4:312–24
52. Boumahdi S, Driessens G, Lapouge G, et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 2014;511:246–50
53. Drilon A, Rekhtman N, Ladanyi M, et al. Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy. Lancet Oncol 2012;13:e418–26
54. Lundberg IV, Edin S, Eklof V, et al. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer. BMC Cancer 2016;16:471
55. Frisch SM, Schaller M, Cieply B. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci 2013;126:21–9
56. Wirth M, Stojanovic N, Christian J, et al. MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib. Nucleic Acids Res 2014;42:10433–47
57. Wu C, Zhang HF, Gupta N, et al. A positive feedback loop involving the Wnt/beta-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. J Hematol Oncol 2016;9:120
58. Arora S, Wang Y, Jia Z, et al. Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome Biol 2008;9:R166
59. Bass AJ, Watanabe H, Mermel CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009;41:1238–42
60. Hussenet T, du Manoir S. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 2010;9:1480–6